Sixty three children with dyspepsia (mean age 12 years, range one to 18, M/F 41/22) were Helicobacter pylori positive by histology of gastric antral biopsy specimens and were treated with a six week course of amoxycillin (50 mg/kg) and tinidazole (20 mg/kg In common with other studies the presence of H pylon on histology was taken as diagnostic of infection.`H pylon positive children were treated with a six week course of amoxycillin (50 mg/kg/day) and tinidazole (20 mg/kg/day), and reinvestigated four weeks after stopping treatment. Children in whom H pylon persisted were treated with a further six week course of amoxycillin and tinidazole. Repeat investigation was offered at six monthly intervals for 18 months.
Several of the difficulties recently posed by the treatment of Helicobacter pylori (H pylori) have been resolved. Thus, while single drug treatment of H pylori with bismuth compounds or antibiotics may clear the organism,' recrudescence is very common, and for effective eradication (defined as the absence of infection four weeks after completion of treatment,2 combined treatment of bismuth with antibiotics is required.'34 Because of concern about possible toxicity, bismuth preparations are not licensed for children in several countries including Italy and the UK. We have previously shown that combined amoxycillin and tinidazole treatment of 32 H pyloni positive children eradicated the infection in more than 90% of cases. ' Little is known of the spread ofH pylori, but in adults successfully treated with bismuth/ antibiotic combinations, relapse during long term follow up has been unusual, and reported 12 month recurrence rates vary between three and 11%.' 3 Patterns of spread, however, may differ in children with an increased risk of relapse as 12 of the 32 children with H pylori successfully treated with combined amoxycillin and tinidazole were reinvestigated six months after completing treatment, and infection had recurred in three (25% were no false positives for either test in patients with negative histology (Table I ). All 63 children completed six weeks of combined amoxycillin and tinidazole treatment. Side effects occurred in six children (nausea in three, and vomiting, vertigo and skin rash each affected one child), but these were mild and it was not necessary to abandon treatment.
Four weeks after stopping treatment, H pylori had been eradicated in 54 children (86%). Fifty one had normal gastric histology, and in the other three gastritis was improved. Ten children (16%) remained H pylori positive, and all had persisting antral gastritis although in seven the inflammation had improved. H pylorn were cultured in five ofthe 10 children, but urease testing was positive in only one child. None of these persistently H pylori positive children had infection eradicated by a further six week course of amoxycillin and tinidazole.
Serum H pylori IgG, pepsinogen I and gastrin concentrations were all decreased four weeks after stopping treatment (IgG-19%, 95% confidence interval (Cl) -13 to -24%, p<0 001; pepsinogen I -27%, 95% Cl -20 to -34%, p<0 001; gastrin -24%, 95% Cl -17 to -31%, p<0Q001, Table II ). Serum IgG concentrations fell in all 54 children in whom infection had been eradicated, and serum pepsinogen I and gastrin concentrations fell in 49 (91%) and 42 (78%) of these children respectively.
At six months, 37 children (59%) were reinvestigated. Thirty one of 34 (91%) in whom H pylori had been eradicated remained negative for infection, including five children with further abdominal pain, and three children had asymptomatic reinfection. Three of the 10 children in whom H pylon' persisted despite treatment were also investigated, and all remained infected but asymptomatic. There were no recurrent peptic ulcers.
At 12 months, 24 children (38%) were reinvestigated. Twenty two in whom H pylori had been eradicated all remained negative, including four children with further pain. Two of the 10 children with persisting H pylori after treatment were investigated and remained infected but asymptomatic. As at six months, there were no recurrent peptic ulcers.
At 18 months, 20 children (32%) were reinvestigated. Sixteen of 18 in whom H pylon had been eradicated remained negative (89%), including two with further pain, and two children had asymptomatic reinfection. Two of the 10 children with persisting H pylon' after treatment were investigated and remained infected; one had an asymptomatic recurrent duodenal ulcer and the other had further pain.
The recurrence rates for the children in whom H pylon' was eradicated and who underwent reinvestigation were: 9% at six months; 0% at 12 months; and 11% at 18 months; yielding a cumulative relapse rate of 20%.
During the 18 month follow up period, concentrations of serum H pylori IgG, pepsinogen I and gastrin remained low in children free from infection (Table II) . Persisting or recurrent infection was invariably associated with a rise in serum H pylon' IgG concentration, but pepsinogen I and gastrin concentration were less reliable (Table II) suggesting that person-to-person spread from other family members is an important source of infection and therefore also of recurrence. This source appears less common in adults for whom there is no increased intrafamily frequency of H pylori compared with controls,'3 and for whom there is some evidence of occupational exposure. '1 Further work on the spread ofHpylori is required.
Six weeks combined amoxycillin and tinidazole treatment is not in line with current trends with shorter courses of treatment, but was selected four years ago as the regime most likely to be effective. Similarly, the problem of metronidazole and tinidazole resistance as a cause of treatment failure was not known, and at that time a repeat course of amoxycillin and tinidazole was considered not unreasonable for failure of eradication.
Marshall et al also showed in adults that if H pylori was not eradicated, infection persisted during follow up for 12 months,' and the present study shows that this is also true for children.
Unfortunately the follow up of the 63 children was incomplete, but there was no evidence that those children reinvestigated were unrepresentative or that the absence of data from those lost to follow materially altered the results.
Most of the children had normal macroscopic appearances or antral gastritis at initial endoscopy, and therefore had H pylon positive nonulcer dyspepsia. Most of those successfully treated were symptom free on follow up suggesting a causal link, but several children had asymptomatic relapse and others remaining H pyloni negative developed recurrent abdominal pain. Therefore, as in adult non-ulcer dyspepsia, it is not clear whether eradication of H pylori improves symptoms in children. At a practical level H pylori status cannot be predicted with certainty from symptoms. The present study has also shown, however, that during prolonged follow up, as in short term healing studies, ' 
